慢性丙型肝炎抗病毒治疗研究的进展

被引：9

作者：

谭德明

周旋

机构：

[1] 中南大学湘雅医院感染病科

来源：

临床肝胆病杂志 | 2012年 / 06期

关键词：

肝炎,丙型,慢性; 白细胞介素类; 多态现象,遗传; 抗病毒药;

D O I：

暂无

中图分类号：

R512.63 [];

学科分类号：

摘要：

<正>丙型肝炎是由HCV引起的一种主要经血液传播的慢性进展性肝脏疾病。据世界卫生组织统计,全球HCV感染率约为3%,估计约1.7～2.0亿人感染了HCV,每年新发丙型肝炎病例约为3.5万例[1,3]。HCV感染后约50%～85%转化为慢性感染[4-5]。HCV慢性感染可导致肝脏慢性炎症坏死及纤维化,部分患者可发展为肝硬化甚至肝细胞癌,对患者的健康及生命危害极大,已成为严重的社会和公共卫生问题[5-7]。HCV

引用

页码：417 / 421

页数：5

共 24 条

[1] 丙型肝炎防治指南 [J].

中华肝脏病杂志, 2004, (04) :7-11

[2]

An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases[J] . Marc G. Ghany,David R. Nelson,Doris B. Strader,David L. Thomas,Leonard B. Seeff.Hepatology . 2011 (4)

[3]

Efficacy of the Protease Inhibitor BI 201335, Polymerase Inhibitor BI 207127, and Ribavirin in Patients With Chronic HCV Infection[J] . Stefan Zeuzem,Tarik Asselah,Peter Angus,Jean–Pierre Zarski,Dominique Larrey,Beat Müllhaupt,Ed Gane,Marcus Schuchmann,Ansgar Lohse,Stanislas Pol,Jean–Pierre Bronowicki,Stuart Roberts,Keikawus Arasteh,Fabien Zoulim,Markus Heim,Jerry O. Stern,George Kukolj,Gerhard Nehmiz,Carla Haefner,Wulf Otto Boecher.Gastroenterology . 2011 (6)

[4]

Impact of insulin resistance on sustained response in HCV patients treated with pegylated interferon and ribavirin: A meta-analysis[J] . Pierre Deltenre,Alexandre Louvet,Maud Lemoine,Abbas Mourad,Laetitia Fartoux,Christophe Moreno,Jean Henrion,Philippe Mathurin,Lawrence Serfaty.Journal of Hepatology . 2011 (6)

[5] Beneficial IL28B genotype associated with lower frequency of hepatic steatosis in patients with chronic hepatitis C [J].

Tillmann, Hans L. ;

Patel, Keyur ;

Muir, Andrew J. ;

Guy, Cynthia D. ;

Li, Josephine H. ;

Lao, Xiang Qian ;

Thompson, Alexander ;

Clark, Paul J. ;

Gardner, Stephen D. ;

McHutchison, John G. ;

McCarthy, Jeanette J. .

JOURNAL OF HEPATOLOGY, 2011, 55 (06) :1195-1200

[6] Reduced dose and duration of peginterferon alfa-2b and weight-based ribavirin in patients with genotype 2 and 3 chronic hepatitis C [J].

Manns, Michael ;

Zeuzem, Stefan ;

Sood, Ajit ;

Lurie, Yoav ;

Cornberg, Markus ;

Klinker, Hartwig ;

Buggisch, Peter ;

Roessle, Martin ;

Hinrichsen, Holger ;

Merican, Ismail ;

Ilan, Yaron ;

Mauss, Stefan ;

Abu-Mouch, Saif ;

Horban, Andryes ;

Mueller, Thomas H. ;

Welsch, Christoph ;

Chen, Rongdean ;

Faruqi, Rab ;

Pedicone, Lisa D. ;

Wedemeyer, Heiner .

JOURNAL OF HEPATOLOGY, 2011, 55 (03) :554-563

[7] Rapid virological response is the most important predictor of sustained virological response across genotypes in patients with chronic hepatitis C virus infection [J].

Fried, Michael W. ;

Hadziyannis, Stephanos J. ;

Shiffman, Mitchell L. ;

Messinger, Diethelm ;

Zeuzem, Stefan .

JOURNAL OF HEPATOLOGY, 2011, 55 (01) :69-75

[8]

1356 QUADRUPLE THERAPY WITH BMS-790052, BMS-650032 AND PEG-IFN/RBV FOR 24 WEEKS RESULTS IN 100% SVR12 IN HCV GENOTYPE 1 NULL RESPONDERS[J] . A. Lok,D. Gardiner,E. Lawitz,C. Martorell,G. Everson,R. Ghalib,R. Reindollar,V. Rustgi,F. McPhee,M. Wind-Rotolo,A. Persson,K. Zhu,D. Dimitrova,T. Eley,T. Guo,D. Grasela,C. Pasquinelli.Journal of Hepatology . 2011

[9]

1363 VX-222 WITH TVR ALONE OR IN COMBINATION WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN IN TREATMENT-NAIVE PATIENTS WITH CHRONIC HEPATITIS C: ZENITH STUDY INTERIM RESULTS[J] . A.M. Di Bisceglie,D.R. Nelson,E. Gane,K. Alves,M.J. Koziel,C. De Souza,T.L. Kieffer,S. George,R.S. Kauffman,I.M. Jacobson,M.S. Sulkowski.Journal of Hepatology . 2011

[10] Randomized Controlled Trial of Pegylated Interferon-Alfa 2a and Ribavirin in Treatment-Naive Chronic Hepatitis C Genotype 6 [J].

Lam, Khoa D. ;

Trinh, Huy N. ;

Do, Son T. ;

Nguyen, Thuan T. ;

Garcia, Ruel T. ;

Nguyen, Tuan ;

Phan, Quang Q. ;

Nguyen, Huy A. ;

Nguyen, Khanh K. ;

Nguyen, Long H. ;

Nguyen, Mindie H. .

HEPATOLOGY, 2010, 52 (05) :1573-1580

← 1 2 3 →